TLR4 and inflammatory bowel disease: It is worth noting that PRSS8 inhibits TLR4-mediated inflammation in human and mouse models of inflammatory bowel disease [43], thereby implicating its plausible relevance to TLR4-mediated inflammation pathways in the context of MG.